BioSenic Company Description

BioSenic S.A., a biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France.

The company offers arsenic trioxide (ATO) and oral arsenic trioxide (OATO) platforms. It also provides medicinal products, including ArsciMed, an intravenous drug to treat autoimmune diseases.

In addition, the company develops 4P004v which is in Phase I clinical trial for veterinary use. BioSenic S.A. is headquartered in Saintes, Belgium.

BioSenic S.A.

Country	Belgium
Industry	Biological Products, Except Diagnostic Substances
Employees	7
CEO	Jean-Luc Vandebroek

Contact Details

Address: Avenue Léon champagne, 3 Saintes, 1480 Belgium
Phone	32 478 27 68 42
Website	biosenic.com

Stock Details

Ticker Symbol	BT1
Exchange	Frankfurt Stock Exchange
Fiscal Year	January - December
Reporting Currency	EUR
SIC Code	2836

Key Executives

Name	Position
Jean-Luc Vandebroek	Chief Executive Officer